Last reviewed · How we verify
NCT06649513: LTOO-XP
Long-term Ophthalmic Outcomes in Ex-premature Infants
trial testing eye drops (Tropicamid) in Retinopathy of Prematurity (ROP) in 210 participants. Not yet recruiting.
1 November 2029
Quick facts
| Lead sponsor | Erasmus Medical Center |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 210 |
| Start date | 1 November 2024 |
| Primary completion | 1 November 2029 |
| Estimated completion | 1 November 2030 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- eye drops (Tropicamid) — full drug profile →
Conditions studied
- Retinopathy of Prematurity (ROP) — all drugs for Retinopathy of Prematurity (ROP) →
- Premature Birth — all drugs for Premature Birth →
Sponsor
Erasmus Medical Center
Who can join
16 and older, any sex, with Retinopathy of Prematurity (ROP) or Premature Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is limited knowledge on ophthalmological outcomes in the adult population that was born prematurely. This study aims to evaluate the ophthalmic outcomes of ex-premature infants that have reached adolescence or adulthood.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06649513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of eye drops (Tropicamid)
Trials testing the same drug.
- NCT04880928 — Comparison Mydriasis by Mydrane With Topical Drop Application · Phase 4 · completed
Other recruiting trials for Retinopathy of Prematurity (ROP)
Currently open trials in the same condition.
- NCT06717412 — Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy · NA · recruiting
- NCT06694103 — The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination · NA · recruiting
- NCT03253263 — A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants · Phase 2 · recruiting
Other Erasmus Medical Center trials
Trials by the same sponsor.
- NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
- NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
- NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
- NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
- NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06649513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
- Last refreshed: 18 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06649513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing